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Mycobacterium avium ssp. paratuberculosis (MAP) is the causative agent of Johne’s
disease (JD), a chronic inflammatory bowel disease of cattle characterized by intermittent
to chronic diarrhea. In addition, MAP has been isolated from Crohn’s disease (CD)
patients. The impact of MAP on severity of clinical symptoms in JD as well as its role in CD
are yet unknown. We have previously shown that MAP is able to colonize inflamed enteric
tissue and to exacerbate the inflammatory tissue response (Suwandi et al., 2014). In the
present study, we analyzed how repeated MAP administration influences the course of
dextran sulfate sodium (DSS)-induced colitis. In comparison to mice exposed to DSS
or MAP only, repeated exposure of DSS-treated mice to MAP (DSS/MAP) revealed a
significantly enhanced clinical score, reduction of colon length as well as severe CD4+ T
cell infiltration into the colonic lamina propria. Functional analysis identified a critical role
of CD4+ T cells in the MAP-induced disease exacerbation. Additionally, altered immune
responses were observed when closely related mycobacteria species such as M. avium
ssp. avium and M. avium ssp. hominissuis were administered. These data reveal the
specific ability of MAP to aggravate intestinal inflammation and clinical symptoms. Overall,
this phenotype is compatible with similar disease promoting capabilites of MAP in JD and
CD.
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INTRODUCTION
Mycobacterium avium ssp. paratuberculosis (MAP) is the cause of Johne’s disease (JD), a chronic
inflammatory disorder of the gastrointestinal tract in ruminants. Clinical symptoms of the disease
include chronic diarrhea and loss of body weight ultimately associated with a fatal wasting disease.
Large numbers of bacteria are shed intermittently during active disease and the contamination of
milk, soil, or water represents the mode of MAP transmission (Cocito et al., 1994). MAP exhibits
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high tenacity illustrated by its ability to survive the pasteurization
process and may thus, to some extent, be present in the human
food chain (Sung and Collins, 1998). The pathogenesis of JD is
the still unclear. However, bacterial survival and proliferation
in sub-epithelial macrophages appear to represent critical steps
promoting the disease (Whittington et al., 2012).
An association of MAP infection with Crohn’s disease (CD)
a chronic inflammatory bowel disease in humans has been
proposed based on the similarity of symptoms as well as
histopathological appearance between JD in ruminants and CD
in humans (Chiodini et al., 1984; Feller et al., 2007; Abubakar
et al., 2008). Studies, comparing the presence of MAP in the
intestine of CD patients, however, have provided contradictory
results (Chiodini et al., 1984; Feller et al., 2007; Abubakar et al.,
2008). This might be due to technical difficulties in the detection
of MAP in clinical samples. For instance, cultivation of MAP on
solid media may require months to years (Bull et al., 2003). On
the other hand, the detection of MAP DNA by PCR, as observed
in some CD patients, does not prove the presence of viable
bacteria. Hence, the question whether MAP plays a causative or
disease promoting role in CD or may only be a silent bystander
still remains unanswered.
Macrophages and/or dendritic cells (DC) initiate the
activation of the adaptive immune system and act as antigen
presenting cells (APC). Upon MAP infection, they secrete
cytokines such as IFN-γ, TNF-α, IL-6, and IL-1β that stimulate
T lymphocyte activation. In turn, CD4+ T cells of T helper 1
type (Th1) are activated and produce IFN-γ. Such MAP specific
CD4+ T cells home to the site of infection and are thought to
restrict bacterial growth (Coussens, 2004). This is consistent with
our previous data showing that systemically applied MAP elicits
signs of systemic and mucosal inflammation and exacerbates
an already existing intestinal inflammation (Koc et al., 2014;
Suwandi et al., 2014). In addition, our previous data suggested
that MAP infection preferentially colonizes inflamed intestinal
tissue (Suwandi et al., 2014), which would explain the elevated
MAP detection rate in clinical samples of CD patients reported in
some studies (Feller et al., 2007). Still, additional so far undefined
cofactors might promote inflammation and explain the outcome
of studies that did not report a significant association of MAP
with CD.
An immune-mediated disease promoting effect of MAPmight
also contribute to JD. Animals are usually infected by MAP
early in life and exhibit a long disease course from the pre-
clinical phase with intermediate diarrhea to the clinical phase
with chronic diarrhea and wasting. It is not clear why chronically
infected animals convert to the overt, clinical phase of JD. One
possible explanation for disease aggravation might be seen as a
consequence of the ongoing, recurrent exposure of immune cells
to MAP or MAP components released from macrophages. Based
on this hypothesis, we performed the present study. It analyzes
the clinical outcome as well as immunological parameters during
dextran sulfate sodium (DSS)-induced colitis in the absence
or presence of repeated exposure to MAP. Interestingly, DSS
treated mice exposed to MAP but not mice treated solely
with DSS or MAP exhibited diarrhea as well as a significant
reduction of colon length. Both, diarrhea and deep intestinal
tissue inflammation are also found in JD and CD. CD4+ T
lymphocytes were identified to drive disease progression in vivo.
Additionally, MAP infection resulted in stronger inflammation
in comparison to closely related M. avium ssp. avium and M.
avium ssp. hominisuis infection. Our results clearly demonstrate
that recurrent exposure to MAP contributes to the aggravation
of inflammation and clinical signs via the stimulation of CD4+ T
cells.
MATERIALS AND METHODS
Bacteria
M. avium ssp. paratuberculosis (MAP) strain DSM 44135 was
grown on Watson Reid medium supplemented with mycobactin
J (1 mg/L) at 37◦C (Kuehnel et al., 2001). M. avium ssp. avium
(MAA) strain DSM 44156 andM. avium ssp. hominissuis (MAH)
strain 04A/1287 were grown in the same medium without
mycobactin J.
Mice
C57BL/6J mice were purchased from Janvier (Le Genest-saint-
Isle, France). RAG2−/− mice were bred at the animal facility of
theHelmholtz Centre for Infection Research (HZI) under specific
pathogen-free conditions (SPF). Female mice at the age of 8–
10 weeks at the beginning of all experiments were used. Animal
studies were carried out under good animal practice conditions
in strict accordance with the German law for animal protection
(Tierschutzgesetz, §7–9) performed under the approval of the
ethics committee of the local authority: LAVES (Nr.:33.14.42502-
04/090/08).
Induction of DSS Induced Colitis and MAP
Infection
Four Pecentage DSS (35–50,000 kDa; MP Biomedical) was
administered via the drinking water from day 1 until day 5.
For infection, mice were intraperitoneally (i.p.) injected with 108
MAP, MAA, or MHS in endotoxin free Dulbecco’s phosphate-
buffered saline (PAA) 2 days after DSS administration (n =
3–5 mice per group). Body weight was monitored 2–3 times
weekly. For secondary challenge, mice were injected 5 weeks post
infection (5wk p.i.). Mice were sacrificed on day 1 post-secondary
challenge. The total weight of liver and spleen were measured
and the organs were harvested for histology. The colon length
was measured, a 1–2 cm section was then obtained for histology,
and the rest was homogenized for plating after washing with PBS.
To deplete CD4 and CD8 T cells, 150 µg/mL anti-CD4 antibody
(Clone GK1.5), anti-CD8 (Clone 53–6.7), or Rat IgG2b isotype
control (eBR2a, eBioscience) as control were administered i.p. 2
days before secondary challenge.
Measurement of Fluid Absorption in Colon
Fluid absorption measurement was performed at Department
of Gastroenterology, Hepatology, and Endocrinology, Hannover
Medical School according to previously published protocols
and described (Singh et al., 2010, 2012). Animals (n = 5 each
group) had free access to food and water before the experiment.
Induction of anesthesia was achieved by spontaneous inhalation
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of isoflurane (Forene; Abbott Germany, Wiesbaden, Germany).
The inhalation gas contained a mixture of ∼10–15% oxygen,
∼85–90% air, and ∼2.0 ± 0.2% isoflurane with the use of an
isoflurane pump (Univentor 1250 Anaesthesia Unit; AgnTho,
Lidingö, Sweden) and was administered continuously via a
breathing mask. The depth of the anesthesia was tested by
probing the pedal withdrawal reflex and breathing rate of the
mice. The gas flow through the cylindrical mask (2 cm long with
an inner diameter of 1.2 cm) was∼200ml/min, whichminimized
rebreathing of exhaled CO2 by the animals. To minimize the
anesthesia level and pain during surgery, all the mice received
subcutaneous injection of 500 mg/kg body weight of Novalgin
30min before the surgery was started. Body temperature was
maintained using a heating pad. A catheter was placed in the
left carotid artery for continuous infusion of (in mM) 200 Na+
and 100 CO−23 at a rate of 0.30 ml/h to prevent anesthesia
induced acidosis. Lower abdomen was opened by one small
central incision, and whole colon was used for measurement.
A small polyethylene tube (PE100) with a distal flange was
advanced into the proximal colon through an opening in cecum
and secured by a ligature that served as an inlet tube. PE200
flanged tubing was secured by ligature to allow for drainage
through the anus in the distal part of the colon. The isolated
colonic segment with an intact blood supply was gently flushed
and then perfused (Perfusor compact; BRAUN, Bethlehem, PA,
USA) at a rate of 3ml/h with 150 mmol/l NaCl. Eﬄuents from
the isolated segment were visually free of blood throughout
all experiments. After an initial 30-min washout and recovery
period, fluid absorption was measured for another 1 h. At the end
of the experiments, mice were killed by cervical dislocation. The
perfused segment was excised from in situ position, and its length
was measured. The perfusate was collected in a pre-weighed 4.5-
ml collecting tube. After a 30-min period, the tube was weighed
again and the difference of the two up to four places of decimal
was taken as the amount of fluid recovered after 30min (taking
density of fluid roughly at about 1 g/ml). The difference was
further subtracted from 1.5 ml, which was the original volume
recovered after 30min in case of no fluid absorption. All values
were represented in milliliters of fluid absorbed per centimeter
colon length per h (ml/cm/h).
Pathology and Histology
Histology was performed in the Mouse Pathology platform at
HZI Braunschweig. Organs were fixed in 10% formaldehyde,
dehydrated with ethanol, and embedded in paraffin. Paraffin
sections (3 µm) were stained with hematoxylin-eosin (H&E) and
Ziehl Neelsen (ZN) staining according to standard laboratory
procedures. Scoring of histopathological changes of colon and
ZN staining evaluation was performed in a blinded fashion
(n = 3–5 mice per group). For scoring of colonic tissue, a
combined score of severity, ulceration, edema, and area involved
was applied. Grades applied for severity were 0 = no alteration,
1 = mild, 2 = moderate, 3 = severe alterations. For ulceration
score, the grading was 0= no ulcer, 1= 1–2 ulcers (involving up
to a total of 20 crypts), 2 = 1–4 ulcers (involving a total of 20–40
crypts) and 3= any ulcers larger than 40 crypts. For edema score,
the grades were 1 = only mild epithelial or submucosal edema,
2 = mild epithelial edema associated with mild submucosal
edema or more moderate submucosal edema, and 3 = every
edema more extensive that the previous. For area involved in the
inflammatory process, the grades were 0 = 0%, 1 ≤ 30%, 2 =
40–70%, 3 ≥ 70%.
ELISA
Colons were flushed with cold PBS, opened along longitudinal
axis, cut into 0.5 cm pieces and incubated for 24 h in RPMI
1640 supplemented with 10% FCS and antibiotics (n = 3–5 mice
per group). Colon supernatants were collected and stored at
−20◦C. TNF-α serum levels were detected using a mouse TNF-α
ELISA kit (Biolegend) according to the manufacturer’s protocol.
Mouse cytokines and chemokines were analyzed using Bio-
plex Pro Mouse Cytokines 23-plex Assay (Bio-Rad) according
to the manufacturer’s protocol. IFN-γ levels in sera or colon
supernatant were measured using an ELISA. Rat anti-mouse
IFN-γ (Molecular Immunology, HZI) in coating buffer were
incubated in 96 well plates (MaxiSorb TM Immunoplates, Nunc)
overnight at 4◦C. The 96 well plates were then blocked for
1 h, with 3% BSA in 0.05% Tween 20. Diluted sera or colon
supernatant were distributed to the wells and incubated for
2 h at room temperature. IFN-γ was detected with biotinylated
anti-mouse IFN-γ antibodies (Molecular Immunology, HZI).
Biotinylated antibodies were bound with horseradish peroxidase
(HRP) conjugated streptavidin (BD Pharmingen). Bound HRP
was determined using o-Phenylendiamin (OPD) as substrate and
the results were read using an ELISA-reader (BioRad 3550-UV
microplate reader) at a wavelength of 490 nm.
Flow Cytometry
Isolation of cells from mesenteric lymph nodes and colonic
lamina propria was performed as described in Zigmond et al.
(2012) with slight modifications (n = 3–5 mice per group).
Cells frommesenteric lymph nodes were prepared by mechanical
dissociation. Cell suspension was passed through 50 µm nylon
filters. Red blood cells were lysed for 2min in ACK buffer (0.15
M NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA). FcR were then
blocked with 1 µg/mL FcR block (rat anti-mouse CD16/CD32,
BD Pharmingen).
Colons were flushed of their luminal content with cold PBS,
opened longitudinally, cut into 0.5 cm pieces and incubated 3x in
HBSS (Ca and Mg free) with 5% FCS, 2mM EDTA, 1mM DTT
and 10mM HEPES at 37◦C with shaking at 250 rpm for 15min
to remove epithelial cells and mucus. Tissue was then digested in
RPMI 1640 with 10% FCS, 1.5 mg/mL collagenase type VIII, and
0.1 mg/mL DnaseI at 37◦C with shaking at 250 rpm for 45min.
Percoll (GE Healthcare) gradients using 40/80% were performed
to purify the leukocytes. The following antibodies were used for
flow cytometry analysis: anti-CD45 APC-Cy7, anti-CD3 FITC,
anti-CD4 APC, anti-CD11c FITC, anti-CD19 PerCP-Cy5.5, anti-
CD8 PE, anti-Ly6C APC, anti-Ly6G PE-Cy7, anti-F4/80 PerCP-
Cy5.5, and anti-CD11b PE. DAPI (Sigma) were used for live
and dead discrimination. Flow cytometry was performed using
a LSR II analyzer (BD, NJ, USA). The data were analyzed using
FACSDiva software (BD) or FlowJo (TreeStar).
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Organ Plating
The mixture of colon and small intestine homogenates (n =
3–5 mice per group) were plated on Middlebrook 7H10
Agar (Difco, Heidelberg, Germany) containing Mycobactin
J (IDVet Innovative Technology, Montpellier, supplemented
with antibiotics [Vancomycin (Roth, Karlsruhe, Germany);
Amphotericin B (Roth); and Nalidixin Acid (Sigma, Munich,
Germany)]. The plates were incubated at 37◦C for up to 8 weeks.
Statistics
All data were analyzed with GraphPad Prism software. In some
figures, statistical differences between groups were determined
by One-way Anova followed by Tukey’s multiple comparison
post-test. The data were considered statistically significant when
p-values were <0.05. ∗p < 0.05, ∗∗p ≤ 0.01,∗∗∗p < 0.001.
RESULTS
Repeated MAP Exposure of DSS Treated
Mice Leads to Diarrhea and Aggravates
Colitis
We have previously observed that i.p. infection of DSS-treated
mice with MAP enhances the preexisting inflammatory response
(Suwandi et al., 2014). In the present study, by using repeated
MAP exposure we investigated the underlying mechanisms
of the MAP-mediated exacerbating effect and its influence
on the clinical outcome of an intestinal inflammation. Since
persistent or recurrent exposure with MAP is thought to occur
under natural conditions, DSS pretreated mice were exposed
to MAP twice during the course of 5 weeks. Four percentage
DSS was administered via the drinking water to adult female
C57BL/6 mice from day −6 until day −2. Following 2 days of
recovery, 108 colony forming units (CFU) MAP were injected
intraperitoneally. MAP exposure was repeated 5 weeks after the
first administration as illustrated in the experimental schedule
(Figure 1A). The 5 week interval was chosen to assure that mice
had recovered from the first round of DSS treatment and MAP
infection. In addition, we noticed that the severity of the reaction
was weaker when the interval was shortened (data not shown).
First, the body weight was monitored (Figures S1A–D). DSS-
treated mice exposed to MAP twice (DSS+MAP+MAP) showed
a significantly enhanced body weight reduction at day 1 post
secondary exposure and delayed subsequent weight gain in
comparison to all other tested conditions. In contrast, DSS-
treated mice infected with MAP only once (DSS+PBS+MAP)
showed a reduction of body weight at 1 day p.i. but recovered
already at day 2 p.i. (Figure S1D). Although the impact on body
weight was not as severe, extended recovery times were also
observed in mice infected twice with MAP without prior DSS
treatment (H2O+MAP+MAP; Figure S1D).
Unexpectedly, mice that were pretreated with DSS and
infected twice withMAP (DSS+MAP+MAP) exhibited transient
diarrhea (Figure 1B). This phenomenon was observed in at least
two of three experiments. Thus, in the presence of a preexisting
mucosal damage, MAP elicits a more severe tissue reaction.
In addition, repeated MAP exposure (H2O+MAP+MAP and
DSS+MAP+MAP) resulted in a reduction of fluid absorption in
the colon leading to clinically overt intestinal disease, irrespective
of a preexisting tissue damage (Figure 1C).
A reduction of the total colon length was detected only
in DSS+MAP+MAP mice consistent with a significantly
enhanced, synergistic tissue inflammation (Figure 2B). Also,
the histological score of colons from DSS+MAP+MAP mice
was significantly higher than the score found in control
animals (Figure 2A). At that time point, H&E staining
of colonic tissue obtained from DSS+MAP+MAP animals
revealed strong infiltration of inflammatory cells, whereas for
instance the tissue of DSS+PBS+PBS animals showed only
a low degree of inflammatory cell infiltration (Figure 2C).
Together, the development of diarrhea, the reduction of colon
length and the enhanced histological score of the mucosal
tissue in DSS+MAP+MAP mice indicate that repeated MAP
administration significantly influences the course of DSS-
induced mucosal tissue damage.
Elevated Cytokine Levels after Secondary
MAP Administration
A marked tissue reaction and weight loss was observed after
secondary infection with MAP. In order to test whether
the systemic influence was induced by soluble mediators,
sera were collected at 6 h after secondary MAP exposure
and the cytokine and chemokine levels were measured by
multiplex analysis. Most cytokines and chemokines tested were
strongly up-regulated in both groups following repeated MAP
exposure, i.e., DSS+MAP+MAP and H2O+MAP+MAP mice
(Supplementary Table 1).
To further extend these results, sera were collected
additionally at 2, 6, and 24 h after secondary infection
and analyzed by ELISA. Again, strongly elevated levels of
TNF-α were observed at 2 h in both DSS+MAP+MAP
and H2O+MAP+MAP mice (Figure 3A). Levels gradually
decreased afterwards. Also, IFN-γ levels were elevated at 2 h,
reached the peak at 6 h and decreased at 24 h after secondary
challenge. Of note, IFN-γ levels remained high in mice that
had received DSS prior to MAP administration (Figure S2A).
Similarly elevated levels of TNF-α and IFN-γ were observed
in supernatants of colonic tissue (Figure S2B). Here TNF-α
levels remained elevated at 24 h in DSS+MAP+MAP mice
consistent with the inflammation and diarrhea observed under
these conditions.
DSS+MAP+MAP Treated Mice Exhibit
Increased MLN Leukocyte Numbers
Mesenteric lymph nodes (mLN) drain the intestinal mucosa and
are located within the mesenteric tissue. In order to investigate
the influence of DSS/MAP-induced mucosal inflammation on
the local lymph node environment, flow cytometric analysis of
suspended lymph node cells was applied. Only mice pretreated
with DSS and receiving MAP showed a consistent increase
of hematopoietic cells (Figure S3). No particular cell type was
preferentially increased indicating an enhanced cell influx or
reduced cell eﬄux.
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FIGURE 1 | MAP secondary infection leads to diarrhea and colitis. (A) Overview of the experimental schedule. (B) Representative mouse with diarrhea at 1 day
after secondary exposure. (C) Fluid absorption from colon in mL × cm−1 × h−1 (n = 5). Graph show a show as Mean ± SEM. *P < 0.05; **p < 0.01, one-way
ANOVA with Tukey’s multiple comparison post-test.
Role of CD4+ T Cells in the DSS/MAP
Induced Colon Inflammation
Consistent with a contribution of CD4+ T cells in the induction
of colitis, secondary infection led to a significant increase of
CD4+ T cells in the colonic lamina propria following DSS
administration in combination with repeated MAP exposure
(Figure 3A). In contrast, the level of CD8+ T cells as well
as CD19+ B cells remained unaltered (Figure S4). Among
the myeloid cells, only PMNs showed a significant increase
(Figure 3B). However, this increase was only associated with
MAP administration and independent of DSS treatment and
therefore not associated with the emergence of enhancedmucosal
inflammation.
To confirm the role of CD4+ T cells in the MAP-
mediated exacerbation of the DSS-induced colitis, we
next treated RAG2−/− mice, which lack T and B cells
with DSS and subsequently challenged them with MAP.
As expected, no reduction of colon length was observed
in the absence of a functional T cell-mediated immunity
(Figure 4A).
To assess the key players for this phenomenon, CD4+
T cells or CD8+ T cells from C57BL/6 WT mice were
individually depleted using anti-CD4 or anti-CD8 antibodies
2 days before secondary MAP challenge (Figure 4B). Colon
length reduction was not observed in mice depleted of
CD4+ T cells (Figure 4C). Conversely, mice depleted
of CD8+ T cells still showed a reduction of colon
length (Figure 4C). Again, no colon length reduction
was observed in DSS+MAP+PBS, DSS+PBS+MAP,
H2O+MAP+PBS and H2O+PBS+MAP control animals
(data not shown).
Consistent with these results, the histology score of colonic
tissue obtained from mice depleted of CD4+ T cells showed
a significant improvement in comparison to mice depleted
of CD8+ T cells or isotype controls (Figure 4D). Moderate
infiltration of inflammatory cells and mild epithelial hyperplasia
was observed in isotype control or CD8+ T cell-depleted
DSS+MAP+MAP mice. In contrast, colonic tissues from
DSS+MAP+MAP mice depleted of CD4+ T cells showed
only mild tissue infiltration by inflammatory cells (Figure 4E,
Figure S5).
Different Immune Reaction to Infection
with Closely Related Mycobacterial
Species
To investigate the immune reaction of closely related
mycobacterial species, we infected DSS-treated mice with
the closely related mycobacterial species M. avium ssp. avium
(MAA) or M. avium ssp. hominissuis (MHS). At 5 weeks after
the first challenge, a secondary challenge was administered
with the same mycobacterial species (Figure 5A). All infected
mice showed an increase in liver weight in comparison to
uninfected animals (Figure 5B). In fact, mice infected with
MAA and MHS exhibited an even higher total spleen weight
in comparison to MAP infected animals (Figure 5C). In
contrast, only DSS-treated and MAP infected mice showed
a significant reduction of colon length after secondary MAP
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FIGURE 2 | Pathology of colon after exposure of DSS pretreated mice to MAP. (A) Histology score of the colon was established at 1 day after secondary
exposure (n = 3–5). n.d, not detected, histology score = 0. (B) Upon the necropsy at 1 day after secondary exposure, colon length was measured. Colon lengths in
cm (n = 3–5). (C) H&E staining colon tissue section at 1 day after secondary exposure. Scale bars, 25 µm. H2O+PBS+PBS (upper left) showed normal tissue.
H2O+MAP+MAP (bottom left) and DSS+PBS+PBS (upper right) showed mild infiltration of inflammatory cells (black arrow). DSS+MAP+MAP (bottom right) showed
high invasion of inflammatory cells (black arrow) and severe epithelial hyperplasia. Graph show a representative of at least two independent experiments, show as
Mean ± SEM. *P < 0.05; **p < 0.01; ***p < 0.001, one-way ANOVA with Tukey’s multiple comparison post-test.
challenge. Neither DSS-treated MAA infected mice nor DSS-
treated MHS infected animals showed this phenomenon
(Figure 5D). Consistent with these results, the histology score
of colon tissue obtained from DSS-treated and MAP infected
mice after secondary MAP challenge showed a significant
higher histology score in comparison to DSS-treated MAA
or MHS infected animals after secondary challenge with the
same bacteria (Figure 5E). Severe transmural invasion of
inflammatory cells, ulceration, moderate edema and severe
epithelial hyperplasia was observed in DSS+MAP+MAP
mice. In contrast, colonic tissues from DSS+MAA+MAA and
DSS+MHS+MHS showed only mild invasion of inflammatory
cells and moderate epithelial hyperplasia (Figure 5F). This
illustrates that high colonic inflammation was specific for MAP
in comparison to the closely related mycobacteria MAA and
MHS. Interestingly, despite that MAP infection showed higher
inflammation, colonization by live MAA in intestine exhibited
higher bacterial loads in comparison to the DSS+MAP+MAP
and DSS+MHS+MHS group (Figure S6). In agreement, ZN
staining of intestine showed very rarely positive signals for
animals of the DSS+MAP+MAP and DSS+MHS+MHS group.
High positive signals were obtained for the DSS+MAA+MAA
group (Figure S7).
DISCUSSION
Here we provide clear evidence that recurrent exposure to
MAP aggravates intestinal inflammation and clinical symptoms
suggesting a disease promoting capability of MAP which might
be of importance in JD and CD.
We provide conclusive evidence for the unique capacity of
MAP to exacerbate DSS-mediated mucosal inflammation in the
colon. We also identify the critical role of CD4+ T cells in this
process consistent with their function in many other animal
models of intestinal inflammation and human IBD (Powrie
et al., 1994; Shale et al., 2013). DSS represents a well-established
widely used murine IBD model. IBD-like clinical symptoms
like diarrhea, bloody feces, reduction of colon length, mucosal
ulceration and loss of body weight develop as a consequence
of DSS administration in the drinking water (Elson et al., 1995;
Wirtz et al., 2007). DSS is known to induce mucosal injury and
inflammation via a direct toxic effect on enterocytes and the
protective mucus layer (Johansson et al., 2010). This provides a
port of entry for intestinal bacteria resulting in an inflammatory
response (Saleh and Elson, 2011; Johansson et al., 2013). In
this model, components of the innate immune system such as
TLRs and the inflammasome are important for tissue repair and
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FIGURE 3 | CD4+ T cells accumulate in colon of DSS-treated
MAP-infected mice after secondary exposure. (A) Frequency of CD4+
(CD3+CD4+) and (B) PMN (CD11b+Ly6GhiLy6Cint) in colonic lamina propria
(n = 3–5). Mean ± SEM. *P < 0.05; ***p < 0.001, n.s, not significant, one-way
ANOVA with Tukey’s multiple comparison post-test.
protection from colitis (Saleh and Elson, 2011). In contrast, the
adaptive immune system represented by TH1 and TH2 CD4
+
cells does not play a critical role and has been shown to only
influence the inflammation during the late course of the disease
(Dieleman et al., 1998). Hence, DSS was selected to cause the
primary lesion. Thus, we took advantage of the DSS model to
examine repeated administration of MAP. Using this model we
could show that i.p. infection with MAP exacerbate an existing
mucosal inflammation by its capacity to stimulate a CD4+ T cell
response.
The observed enhanced loss in body weight and delayed
recovery in mice exposed to both, DSS and MAP were
moderate following a single MAP administration. These
finding were consistent with our previous data (Suwandi
et al., 2014). Remarkably, symptoms were significantly more
pronounced after repeated challenge suggesting aggravation of
inflammation. Therefore, the pronounced reduction of body
weight after repeated challenge with MAP was most likely
due to the high cytokine and/or chemokine levels secreted by
adaptive immune cells in response to secondary mycobacterial
exposure. However, the bacteria-induced immune stimulation
could not be the sole explanation, since the clinical course
in DSS+MAP+MAP mice was much more severe than in
H2O+MAP+MAP treated animals. Rather, the DSS-induced
preexisting intestinal inflammation significantly contributed to
the observed phenotype. Thus, the immune response elicited
either by MAP itself or by MAP-induced host components,
exacerbated the DSS-mediated tissue damage. Strikingly, this
exacerbation even led to diarrhea, a symptom rarely observed
in mice. In addition, it led to a strong local inflammatory
reaction illustrated by a reduction of colon length and the
infiltration of immune cells resembling the clinical picture of
CD or JD. Interestingly, in our current study as well as in
our previous work (Suwandi et al., 2014), low colonization
of the intestine by MAP was observed. In accordance, Ziehl-
Neelsen (ZN) staining did only very rarely reveal positive
signals.
Functionally, a significant reduction of fluid absorption at
the colon mucosa was observed after secondary challenge with
MAP even in the absence of DSS-pretreatment. Similarly, also
the MAP induced increase in TNF-α and IFN-γ in serum or in
colon tissue supernatants was independent of preexisting DSS-
mediated inflammation. In accordance, a previous study reported
that administration of antagonistic anti-CD3 antibodies was
able to prevent net water absorption. Such anti-CD3 treatment
also caused systemic cytokine release and acute TNF-dependent
diarrhea (Musch et al., 2002; Clayburgh et al., 2005). Hence, we
assume that both the innate immune system as well as memory
cells of the adaptive immune system react to the repeated MAP
exposure. Particularly CD4+ T cells might be stimulated to
secrete cytokines such as TNF-α and IFN-γ leading to a reduction
of fluid absorption and diarrhea.
Most likely, different cellular mechanisms are responsible
for the inflammatory reaction and the shortening of the
colon. Analysis of the draining MLN did not reveal a clear
increase of a particular cell type irrespective of the type of
stimulation. In contrast, an increased frequency of PMNs
was observed in the lamina propria of the colon. This
increase, however, was observed in all groups receiving MAP
administration. Thus, the recruitment of PMNs is most likely
owed solely to the MAP exposure. In contrast, the increased
frequency of inflammatory monocytes in all DSS-treated and
MAP infected mice was probably due to the primary lesion.
Since recruitment of inflammatory monocytes is essential for
controlling and clearing bacterial infections (Shi and Pamer,
2011), the presence of such cells might suggest an ongoing
translocation of commensal bacteria derived from the enteric
microbiota.
The reduction of colon length in the DSS-treated and
repeatedly MAP infected group required CD4+ T cells as shown
by depletion experiments. In accordance, this cell population
was up-regulated in the colon tissue of DSS+MAP+MAP
mice. CD4+ T cells are known to play an important role
during mycobacterial infections (Ehlers and Schaible, 2012).
The presence of CD4+ T cells accelerates the granulomatous
anti-mycobacterial response by an enhanced production of
TNF-α and IFN-γ at the site of infection (Hänsch et al.,
1996). On the other hand, CD4+ T cells are also important
in the pathogenesis of colitis. Clonal T cell populations
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FIGURE 4 | Role of CD4+ T cells in colitis. (A) Upon the necropsy at 1 day after secondary exposure, colon length of RAG−/− mice was measured. Colon lengths
in cm (n = 4–6). (B) Experimental scheme for CD4 and CD8 T cell depletion. (C) Colon Length of CD4 or CD8 depleted and IgG Isotype control mice (n = 3–4). (D)
Histology score of the colon analyzed at 1 day after secondary exposure (n = 3–5). (E) H&E staining of colon tissue sections at day 1 after secondary exposure. Scale
bars, 25 µm. H2O+PBS+PBS (upper part) showed normal tissue. DSS+MAP+MAP IgG isotype (middle) showed mild invasion of inflammatory cells (black arrow)
and moderate epithelial hyperplasia with desquamation of epithelial cells into the lumen (purple arrow). DSS+MAP+MAP depleted CD4+ T cells (bottom) showed mild
invasion of inflammatory cells (black arrow). Graph show a representative of at least two independent experiments, show as Mean ± SEM. n.s, not significant, *P <
0.05; ***p < 0.001, one-way ANOVA with Tukey’s multiple comparison post-test.
specific for bacterial antigens can induce colitis (Kullberg
et al., 2003). In addition, CD4+ T cells with high expression
of CD45RB are able to induce pathogenic TH1 responses
that lead to colitis (Powrie et al., 1994). Based on our
results, we suggest that MAP specific CD4+ T cells are
activated upon repeated challenge. This induces the maturation
of colitogenic effector T cells. The stronger inflammatory
effect in DSS-treated mice illustrated by the reduction in
colon length and elevated histological score might result
from a synergistic effect between mycobacteria-specific T cell
responses, the acute innate immune response to mycobacterial
constituents and the underlying tissue impairment caused byDSS
treatment.
Interestingly, mice exposed to both, DSS and MAP exhibited
symptoms of severe intestinal inflammation. In contrast, the
closely related mycobacteria MAA and MHS caused milder
intestinal inflammation in combination with DSS, despite of their
potent immune-activating activity illustrated by the enhanced
liver and spleen tissue weight. In addition, MAA colonized the
intestine (small intestine and colon) in high numbers as revealed
by plating and ZN staining. Severely reduced numbers of MAP
and MHS were observed under these conditions by plating while
ZN staining rarely revealed positive signals. Most likely high
proliferation of MAA is responsible for the high colonization
although MHS might proliferate but could be controlled by
the immune system. Thus, far, we never found evidence for
proliferation of MAP in our animal models.
The differential induction of intestinal inflammation by the
three mycobacteria might be due to a particular cell tropism
of MAP to myeloid cells of the intestine i.e., a particular
localization in the colon which could not be revealed by
histology, Alternatively, MAP might induce a CD4+ T cell
response to self-components or constituents of the enteric
microbiota driving colitis in individuals suffering from an
underlying mucosal disease. This clearly needs more intensive
studies in the future. However, the overall results would be in
accordance with our original hypothesis that MAP exacerbates
a pre-existing injury of the intestine and suggests that MAP
might represent an aggravating factor in the development of
IBD. In conclusion, our results demonstrate a strong mucosal
immune response to repeated MAP infection in animals with
a preexisting colon disease. The repeated challenge with MAP
causes re-activation of CD4+ T cells leading to a severe
mucosal inflammation. In addition, it induces a massive cytokine
release that is known to lead to diarrhea. Thus, at least two
mechanisms appear to contribute to disease severity: first,
impairment of the epithelial barrier function likely due to
cytokine secretion, and second, a MAP stimulated immune cell
activation that amplifies the cytokine production and, together
with the preexisting tissue impairment, aggravates the mucosal
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FIGURE 5 | Different responses elicited by infection closely related mycobacterial species after secondary exposure. (A) Experimental scheme. (B–D)
Upon necropsy at 1 day after secondary exposure, colon length, liver and spleen weight were measured. (B) Total liver weight in Gram. (C) Total spleen weight in
Gram. (D) Colon length of MAP, MAA and MHS infected group at 1 day after secondary exposure with the same mycobacteria species (n = 3–5). (E) Histology score
of the colon analyzed at 1 day after secondary exposure (n = 3–5). n.d = not detected, histology score = 0. (F) H&E staining of colon tissue sections at day 1 after
secondary exposure. Scale bars, 25 µm. H2O+PBS+PBS (upper left) showed normal tissue. DSS+PBS+PBS (upper right) showed mild invasion of inflammatory
cells (black arrow), mild epithelial hyperplasia and desquamation of epithelial cells (purple arrow). DSS+MAA+MAA (middle left) showed mild invasion of inflammatory
cells (black arrow), moderate epithelial hyperplasia. DSS+MHS+MHS (middle right) showed mild invasion of inflammatory cells (black arrow), mild edema (green
arrow), moderate epithelial hyperplasia. DSS+MAP+MAP (bottom part) showed severe transmural invasion of inflammatory cells (black arrow), ulceration (red arrow),
moderate edema (green arrow) and severe epithelial hyperplasia. Graph show a representative of at least two independent experiments, show as Mean ± SEM. *P <
0.05; **p < 0.01; ***p < 0.001, one-way ANOVA with Tukey’s multiple comparison post-test.
inflammation resembling IBD. Importantly, both phenomena
result in typical clinical symptoms seen in JD and CD.
Thus, the presented model provides important molecular and
cellular clues on the association of MAP infection in intestinal
inflammation.
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Supplementary Figure 1 | Body weight measurement. (A–D) Weight change
during experiment, expressed as percentage change from day 1 of DSS
treatment. (A) Graph shown from whole experiment. (B) The graph shown is only
from 5 week after first exposure. (C) Graph shown % body weigh measurement at
day 0, 1, and 2 post first exposure. (D) Graph shown % body weight
measurement at day 0, 1, 2, and 4 post secondary exposure at 5 weeks. Graph
show a representative of more than three independent experiments (n = 4–5).
∗P < 0.05; ∗∗∗p < 0.001; n.s, not significant, Mann-Whitney test.
Supplementary Figure 2 | Elevated cytokine levels after secondary
administration of MAP. (A,B) Kinetics of TNF-α and IFN-γ in serum and colon
supernatant at 2, 6, and 24 h after secondary challenge (n = 3–5). (A) Cytokines
level in serum (B) secretion of cytokines into the supernatant of overnight cultured
colon, show as Mean ± SEM. n.d = not detected.
Supplementary Figure 3 | Cellularity in mesenteric lymph nodes. (A,B) Flow
cytometry on leukocytes in mLN at 1 day after secondary exposure. (A) Flow
cytometry gating strategy for myeloid cells and lymphocytes from mLN. (B) Total
cell numbers of CD4+ (CD3+CD4+) and CD8+ (CD3+CD8+) T cells, CD19+ B
cells, dendritic cells (CD11b+CD11chi), PMN (CD11b+Ly6GhiLy6Cint),
monocytes (CD11b+Ly6ChiLy6Gint) and macrophage (CD11b+ Ly6Glo
Ly6CloF4/80lo) (n = 3–5). Graph show a representative of at least two
independent experiments. ∗P < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001, one-way
ANOVA with Tukey’s multiple comparison post-test.
Supplementary Figure 4 | Cellularity in colonic lamina propria. (A,B) Flow
cytometry on leukocytes in colonic lamina propria at 1 day after secondary
exposure. (A) Flow cytometry gating strategy for myeloid cells and lymphocytes
from colonic lamina propria. (B) Frequency of CD19+ B cells, CD4+
(CD3+CD4+), and CD8+ (CD3+CD8+) T cells, dendritic cells (CD11b+
CD11chi), PMN (CD11b+Ly6GhiLy6Cint), inflammatory monocytes
(CD11b+Ly6ChiLy6Gint) and macrophages (CD11b+Ly6GloLy6CloF4/80hi) in
colonic lamina propria (n = 3–5). ∗P < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001, n.s, not
significant, one-way ANOVA with Tukey’s multiple comparison post-test.
Supplementary Figure 5 | Role of CD4+ T cells in colitis. H&E staining of
colon tissue sections at day 1 after secondary exposure. Scale bars, 25 µm.
H2O+PBS+PBS (upper left) showed normal colonic tissue. DSS+PBS+PBS,
DSS+PBS+MAP, DSS+MAP+PBS, H2O+MAP+MAP, and DSS+MAP+MAP
depleted CD4+ T cells (bottom second from the left) showed mild invasion of
inflammatory cells (black arrow). DSS+MAP+MAP IgG isotype (upper right)
showed mild invasion of inflammatory cells (black arrow), moderate epithelial
hyperplasia with desquamation of epithelial cells into the lumen (purple arrow
showing epithelial desquamation). DSS+MAP+MAP depleted CD8+ T cells
showed moderate invasion of inflammatory cells (blue arrow), moderate erosion of
goblet cells and epithelial cells (green arrow), and desquamation of epithelial cells
into the gut lumen (purple arrow showing epithelial desquamation).
Supplementary Figure 6 | Viable bacteria in intestine by infection closely
related mycobacterial species after secondary exposure. Bacterial loads in
intestine (CFU/g intestine) were analyzed at 1 day after secondary exposure with
the same mycobacteria species by plating intestine on Middlebrook Agar (n =
3–5). ∗∗∗p < 0.001, one-way ANOVA with Tukey’s multiple comparison post-test.
Supplementary Figure 7 | ZN staining of organs by infection closely
related mycobacterial species after secondary exposure. ZN staining of
colon (upper part), mesentery (middle part) and small intestine (bottom part) of
DSS+MAP+MAP (left), DSS+MAA+MAA (middle), and DSS+MHS+MHS (right)
groups, showed high positive signal (black arrow) in mesentery of all groups. Only
in DSS+MAA+MAA group revealed high positive signal (black arrow) in colon
(upper part in the middle) and small intestine (bottom part in the middle), which did
not reveal in DSS+MAP+MAP and DSS+MHS+MHS. Scale bars, 25 µm.
Supplementary Table 1 | Cytokines and chemokines level using multiplex
assay at 0 and 6 h post second infection. Data are presented in pg/mL. OOR,
Out of Range; OOR>, Out of Range Above; OOR<, Out of Range Below.
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